Reversal of multidrug resistance in drug-resistant human gastric cancer cell line SGC7901/VCR by antiprogestin drug mifepristone

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 12

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

327

HTML

2008

Figures (1-2)

165

Tables (1-4)

192

Sum=2692

Jun 15, 2004 (publication date) through Jul 29, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Gastric Cancer

World J Gastroenterol. Jun 15, 2004; 10(12): 1722-1725
Published online Jun 15, 2004. doi: 10.3748/wjg.v10.i12.1722

Table 4 Effects of mifepristone on the sensitivity of SGC7901 cells and its drug-resistant counterpart SGC7901/VCR to VCR

Data represent IC₅₀ values of VCR (nmol/L) expressed as mean ± SD of 3 independent experiments.

^aP < 0.005,

^bP < 0.01, vs control group.

Citation: Li DQ, Wang ZB, Bai J, Zhao J, Wang Y, Hu K, Du YH. Reversal of multidrug resistance in drug-resistant human gastric cancer cell line SGC7901/VCR by antiprogestin drug mifepristone. World J Gastroenterol 2004; 10(12): 1722-1725
URL: https://www.wjgnet.com/1007-9327/full/v10/i12/1722.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i12.1722